Explore by Goal

Biochemistry

Evidence-qualified findings from BGPT · Updated October 20, 2026

Two mutations switch esterase into hydroxynitrile lyase
G12T and M239K converted the esterase SABP2 into a hydroxynitrile lyase (20 mU/mg), though activity stayed ~1300-fold below natural enzymes and the variant was barely enantioselective (E = 1.5) — possibly re-enacting a real evolutionary transition.
Enzyme evolution through conformational tuning
A 2021 review argues remote mutations act as conformational "ratchets" locking active sites into productive states, with a striking 680-fold vs 16-fold epistasis example — but it stays qualitative and offers no predictive protocol.
glcN6P cofactor plays four catalytic roles in glmS ribozyme
Thio-effect kinetics, metal rescue, and QM/MM support four distinct cofactor roles, including nucleophile activation via disrupting an inhibitory hydrogen bond — though simulations were short (~1 ps) and trajectory-dependent.
E. coli glucosamine synthetase active-site cysteine assignment
The 1987 study achieved the first homogeneous purification and located the glutamine site at the N-terminal cysteine via radiolabeled DON, though oligomeric-state estimates (127–210 kDa) conflicted internally.

Do molecular chaperones have to be proteins?
Ellis's 1997 commentary cited in vitro evidence that 23S rRNA and phosphatidylethanolamine can assist folding, while candidly flagging that both claims lacked in vivo validation.
Gel electrophoresis for protein folding studies
Goldenberg and Creighton's 1984 transverse urea-gradient gels visualized unfolding transitions and folding intermediates from tiny samples, but mobility-based stability estimates remained qualitative and condition-sensitive.
AIF functional plasticity via dimerization and CHCHD4
A dimerization-defective AIF only partially impaired respiration, and CHCHD4 binding allosterically rescued variants including pathogenic R422Q — but evidence came from n=3–4 fibroblast assays with no in vivo data.

ATP: energy currency and possible non-energetic roles
E. coli intracellular ATP spans 0.2–1.32 mM across conditions — exactly the range where protein-solubilization effects would vary — yet fitness defects track carbon energetics, leaving non-energetic roles untested in vivo.
Moonlighting enzymes with strongest causal validation
PKM2, GAPDH, and GLS show cross-species, cross-cell-type causal support, while TKT, ASNS, LDH-A, ENO-1, and SCD remain single-context or inhibitor-dependent claims.
Colorimetric assay for glucose-6-phosphate
The WST-1/NADP+ cycling assay reached 0.15 µM LOD with formal validation, but only in one matrix (serum), leaving matrix redox sensitivity unquantified.

PAF acetylhydrolases overview and update
The 2018 review frames PAF-AH as a biomarker-target conflation case after darapladib's failed trials, candidly noting that bona fide in vivo substrates remain unknown.
Methods to assess free radicals and oxidative stress
The 1999 review's warning that damage biomarkers (TBARS, 8-OHdG) are correlational rather than causal evidence of radical activity remains the field's most under-heeded lesson.
Phenothiazines inhibit ATP synthase via F0 and F1
The 1990 study showed 48% of phenothiazine inhibition persisted after F1 detachment, implicating F0 — but was limited to bovine enzyme in vitro with sites unidentified.

Riboflavin-biotin chimera binding characterization
C6-Rf-biotin-tag bound apoRBP (KD 1.29 µM) and streptavidin (KD 3.00 µM) by PWR, but the simultaneous dual-binding claim remained unproven and replicate/error details were absent.
Proteose peptone 3 fractionation by dual-salt HIC
Epoxy-Sepharose with ammonium sulfate plus citrate selectively fractionated PP3 forms from whey, but yields, replicates, and key blots were reported as "not shown."
Bacterial sliding clamp inhibitors mimicking linear motifs
Tetrahydrocarbazole inhibitors remodel a protein surface via residue-pair switching to reveal a novel allosteric pocket, though potency was weak (11–17 µM) and no cell-permeability or in vivo data existed.

HAI-2 variants: syndromic vs non-syndromic diarrhea
All five CSD-causing HAI-2 variants lost prostasin inhibition, but only the milder non-syndromic Y68C also lost matriptase inhibition (p < 0.001) — resting on qualitative N=3 blots in one cell line.
Can a single residue set beta-glucan linkage position?
BGPT scored 15% likelihood: I551 sits inside the switch motif whose replacement abolished MLG production entirely, so single-residue sufficiency is logically unsupported.
Does BMBL282 hydrolyze meropenem like imipenem?
No direct 300 nm assay exists; indirect evidence (2-fold vs 8-fold MIC shifts) predicts weak or no meropenem turnover, and the paper itself names the missing test as its falsification criterion.
Author profile: Ravi R Sonani
H-index 22 with ~2,017 citations reflects a mid-career shift from phycobiliprotein biochemistry into cryo-EM filament biology, including a 2022 Cell paper — not yet as first-author driver of high-impact structures.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.